Speaker illustration

Doctor Isabel Mattig

Charite University Hospital, Berlin (Germany)

Member of:

Heart Failure Association

Screening for amyloidosis in patients scheduled for aortic valve replacement

Event: Heart Failure 2024

Topic: Aortic Valve Intervention

Session: Interventional cardiology

Thumbnail

Tolerance and clinical response to SGL2 inhibitors in Fabry disease

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: ePosters in chronic heart failure - pharmacotherapy 3

Thumbnail

Mitral valve thickness: A promising echocardiographic parameter for distinguishing between cardiac amyloidosis and Fabry disease

Event: EACVI 2023

Topic: Myocardial Disease

Session: Cardiac Amyloidosis 2

Thumbnail

New echocardiographic approaches to differentiate cardiac amyloidosis and Fabry disease: the right heart and mitral valve thickness

Event: ESC Congress 2022

Topic: Tissue Doppler, Speckle Tracking and Strain Imaging

Session: Risk stratification of cardiomyopathies with echocardiography

Thumbnail

Case report on a transthyretin-related amyloidosis caused by Leu32Val mutation and its interdisciplinary challenge.

Event: ESC Congress 2021 - The Digital Experience

Topic: Myocardial Disease

Session: Acute and chronic heart failure

Thumbnail

Impact of caval vein implantation on severity of tricuspid regurgitation, renal and hepatic function in patients with severe secondary tricuspid regurgitation

Event: ESC Congress 2020

Topic: Tricuspid Valve Intervention

Session: Novelty in Percutaneous Mitral and Tricuspid Valve Interventions

Thumbnail

ESC 365 is supported by